Literature DB >> 22238065

Production of different glycosylation variants of the tumour-targeting mAb H10 in Nicotiana benthamiana: influence on expression yield and antibody degradation.

Raffaele Lombardi1, Marcello Donini, Maria Elena Villani, Patrizia Brunetti, Kazuhito Fujiyama, Hiroyuki Kajiura, Matthew Paul, Julian K-C Ma, Eugenio Benvenuto.   

Abstract

We previously described the expression of a tumour-targeting antibody (mAb H10) in Nicotiana benthamiana by vacuum-agro-infiltration and the remarkable yields of highly pure protein achieved. The objective of the present work was to investigate different strategies for transient overexpression of the mAb H10 in which glycan configuration was modulated and assess how these strategies affect the accumulation yield and stability of the antibody. To this aim, three procedures have been assayed: (1) Site-directed mutagenesis to abolish the glycosylation site; (2) endoplasmic reticulum retention (C-terminal SEKDEL fusion) to ensure predominantly high-mannose type glycans; and (3) expression in a N. benthamiana RNAi down-regulated line in which β1,2-xylosyltransferase and α1,3-fucosyltransferase gene expression is silenced. The three antibody variants (H10-Mut) (H10-SEKDEL) (H10(XylT/FucT)) were transiently expressed, purified and characterised for their glycosylation profile, expression/purification yield and antibody degradation pattern. Glycosylation analysis of H10(XylT/FucT) demonstrated the absence of plant complex-type sugars, while H10-SEKDEL, although substantially retained in the ER, revealed the presence of β1,2-xylose and α1,3-fucose residues, indicating a partial escape from the ER retrieval system. Antibody accumulation and purification yields were not enhanced by ER retention. All H10 antibody glyco-forms revealed greater degradation compared to the original, resulting mostly in the formation of Fab fragments. In the case of aglycosylated H10-Mut, more than 95% of the heavy chain was cleaved, confirming the pivotal role of the sugar moiety in protein stability. Identification of possible 'fragile' sites in the H10 antibody hinge region could be of general interest for the development of new strategies to reduce antibody degradation and increase the yield of intact IgGs in plants.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22238065     DOI: 10.1007/s11248-012-9587-1

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  42 in total

1.  Glycosylation influences on the aggregation propensity of therapeutic monoclonal antibodies.

Authors:  Veysel Kayser; Naresh Chennamsetty; Vladimir Voynov; Kurt Forrer; Bernhard Helk; Bernhardt L Trout
Journal:  Biotechnol J       Date:  2011-01       Impact factor: 4.677

2.  Plant-derived mouse IgG monoclonal antibody fused to KDEL endoplasmic reticulum-retention signal is N-glycosylated homogeneously throughout the plant with mostly high-mannose-type N-glycans.

Authors:  Ada Triguero; Gleysin Cabrera; José A Cremata; Chun-Ting Yuen; Jun Wheeler; Nadia I Ramírez
Journal:  Plant Biotechnol J       Date:  2005-07       Impact factor: 9.803

3.  A functional antibody lacking N-linked glycans is efficiently folded, assembled and secreted by tobacco mesophyll protoplasts.

Authors:  James Nuttall; Julian K-C Ma; Lorenzo Frigerio
Journal:  Plant Biotechnol J       Date:  2005-09       Impact factor: 9.803

4.  Immunoreactivity in mammals of two typical plant glyco-epitopes, core alpha(1,3)-fucose and core xylose.

Authors:  Muriel Bardor; Christelle Faveeuw; Anne-Catherine Fitchette; Danièle Gilbert; Ludovic Galas; Francois Trottein; Loïc Faye; Patrice Lerouge
Journal:  Glycobiology       Date:  2002-12-17       Impact factor: 4.313

5.  Production of monoclonal antibodies with a controlled N-glycosylation pattern in seeds of Arabidopsis thaliana.

Authors:  Andreas Loos; Bart Van Droogenbroeck; Stefan Hillmer; Josephine Grass; Renate Kunert; Jingyuan Cao; David G Robinson; Ann Depicker; Herta Steinkellner
Journal:  Plant Biotechnol J       Date:  2011-02       Impact factor: 9.803

6.  Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor.

Authors:  Kevin M Cox; Jason D Sterling; Jeffrey T Regan; John R Gasdaska; Karen K Frantz; Charles G Peele; Amelia Black; David Passmore; Cristina Moldovan-Loomis; Mohan Srinivasan; Severino Cuison; Pina M Cardarelli; Lynn F Dickey
Journal:  Nat Biotechnol       Date:  2006-11-26       Impact factor: 54.908

7.  Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure.

Authors:  Richard Strasser; Johannes Stadlmann; Matthias Schähs; Gabriela Stiegler; Heribert Quendler; Lukas Mach; Josef Glössl; Koen Weterings; Martin Pabst; Herta Steinkellner
Journal:  Plant Biotechnol J       Date:  2008-03-13       Impact factor: 9.803

8.  Production of mouse monoclonal antibody with galactose-extended sugar chain by suspension cultured tobacco BY2 cells expressing human beta(1,4)-galactosyltransferase.

Authors:  Kazuhito Fujiyama; Aiko Furukawa; Atsuya Katsura; Ryo Misaki; Takeshi Omasa; Tatsuji Seki
Journal:  Biochem Biophys Res Commun       Date:  2007-04-19       Impact factor: 3.575

9.  Biochemical and functional characterization of anti-HIV antibody-ELP fusion proteins from transgenic plants.

Authors:  Doreen M Floss; Markus Sack; Johannes Stadlmann; Thomas Rademacher; Jürgen Scheller; Eva Stöger; Rainer Fischer; Udo Conrad
Journal:  Plant Biotechnol J       Date:  2008-02-28       Impact factor: 9.803

10.  Expression, intracellular targeting and purification of HIV Nef variants in tobacco cells.

Authors:  Carla Marusic; James Nuttall; Giampaolo Buriani; Chiara Lico; Raffaele Lombardi; Selene Baschieri; Eugenio Benvenuto; Lorenzo Frigerio
Journal:  BMC Biotechnol       Date:  2007-02-26       Impact factor: 2.563

View more
  3 in total

1.  Expression of human butyrylcholinesterase with an engineered glycosylation profile resembling the plasma-derived orthologue.

Authors:  Jeannine D Schneider; Alexandra Castilho; Laura Neumann; Friedrich Altmann; Andreas Loos; Latha Kannan; Tsafrir S Mor; Herta Steinkellner
Journal:  Biotechnol J       Date:  2013-11-08       Impact factor: 4.677

2.  Generation of biologically active multi-sialylated recombinant human EPOFc in plants.

Authors:  Alexandra Castilho; Laura Neumann; Pia Gattinger; Richard Strasser; Karola Vorauer-Uhl; Thomas Sterovsky; Friedrich Altmann; Herta Steinkellner
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

3.  The human anti-HIV antibodies 2F5, 2G12, and PG9 differ in their susceptibility to proteolytic degradation: down-regulation of endogenous serine and cysteine proteinase activities could improve antibody production in plant-based expression platforms.

Authors:  Melanie Niemer; Ulrich Mehofer; Juan Antonio Torres Acosta; Maria Verdianz; Theresa Henkel; Andreas Loos; Richard Strasser; Daniel Maresch; Thomas Rademacher; Herta Steinkellner; Lukas Mach
Journal:  Biotechnol J       Date:  2014-04       Impact factor: 4.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.